Dynamic behavior of hepatitis C virus quasispecies in a long-term culture of the three-dimensional radial-flow bioreactor system

Journal of Virological Methods

Volumn 148, Issue 1-2, 2008, Pages 174-181

  Murakami, Kyoko ^a   Inoue, Yasushi ^a,b   Hmwe, Su Su ^a,c   Omata, Kazuhiko ^a,d   Hongo, Tomokatsu ^e   Ishii, Koji ^a   Yoshizaki, Sayaka ^a   Aizaki, Hideki ^a   Matsuura, Tomokazu ^f   Shoji, Ikuo ^a   Miyamura, Tatsuo ^a   Suzuki, Tetsuro ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b International University of Health and Welfare Mita Hospital   (Japan)

^c GRADUATE SCHOOL OF MEDICINE   (Japan)

^d NIPPON DENTAL UNIVERSITY   (Japan)

^e ABLE Corporation   (Japan)

^f JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dynamics; Hepatitis C virus; Quasispecies; Radial flow bioreactor; Three dimensional culture

Indexed keywords

ALPHA INTERFERON; CORE PROTEIN; VIRUS RNA;

ARTICLE; BIOREACTOR; CELL CULTURE; CELL FUNCTION; CELL STRUCTURE; CONTROLLED STUDY; GENETIC VARIABILITY; GENOME; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; INFECTION; LIVER CELL; LIVER CELL CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS EXPRESSION;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BIOREACTORS; CELL LINE, TUMOR; HEPACIVIRUS; HUMANS; RNA, VIRAL; SELECTION (GENETICS); SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; VARIATION (GENETICS); VIRAL CORE PROTEINS; VIRUS CULTIVATION;

HEPATITIS C VIRUS;

EID: 39149117664     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2007.11.001     Document Type: Article

References (35)

1. Aizaki H., Aoki Y., Harada T., Ishii K., Suzuki T., Nagamori S., Toda G., Matsuura Y., and Miyamura T. Full-length complementary DNA of hepatitis C virus genome from an infectious blood sample. Hepatology 27 (1998) 621-627
2. Aizaki H., Nagamori S., Matsuda M., Kawakami H., Hashimoto O., Ishiko H., Kawada M., Matsuura T., Hasumura S., Matsuura Y., Suzuki T., and Miyamura T. Production and release of infectious hepatitis C virus from human liver cell cultures in the three-dimensional radial-flow bioreactor. Virology 314 (2003) 16-25
3. Aoki Y., Aizaki H., Shimoike T., Tani H., Ishii K., Saito I., Matsuura Y., and Miyamura T. A human liver cell line exhibits efficient translation of HCV RNAs produced by a recombinant adenovirus expressing T7 RNA polymerase. Virology 250 (1998) 140-150
4. Bartenschlager R., Kaul A., and Sparacio S. Replication of the hepatitis C virus in cell culture. Antivir. Res. 60 (2003) 91-102
5. Blight K.J., Kolykhalov A.A., and Rice C.M. Efficient initiation of HCV RNA replication in cell culture. Science 290 (2000) 1972-1974
6. Boriskin Y.S., Pecheur E.I., and Polyak S.J. Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection. Virol. J. 3 (2006) 56
7. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., and Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244 (1989) 359-362
8. Choo Q.L., Richman K.H., Han J.H., Berger K., Lee C., Dong C., Gallegos C., Coit D., Medina-Selby R., Barr P.J., et al. Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 2451-2455
9. Dahari H., Major M., Zhang X., Mihalik K., Rice C.M., Perelson A.S., Feinstone S.M., and Neumann A.U. Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production. Gastroenterology 128 (2005) 1056-1066
10. Dixit N.M., Layden-Almer J.E., Layden T.J., and Perelson A.S. Modelling how ribavirin improves interferon response rates in hepatitis C virus infection. Nature 432 (2004) 922-924
11. Grakoui A., McCourt D.W., Wychowski C., Feinstone S.M., and Rice C.M. Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. J. Virol. 67 (1993) 2832-2843
12. Hijikata M., Kato N., Ootsuyama Y., Nakagawa M., and Shimotohno K. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 5547-5551
13. Hijikata M., Shimizu Y.K., Kato H., Iwamoto A., Shih J.W., Alter H.J., Purcell R.H., and Yoshikura H. Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. J. Virol. 67 (1993) 1953-1958
14. Hongo T., Kajikawa M., Ishida S., Ozawa S., Ohno Y., Sawada J., Umezawa A., Ishikawa Y., Kobayashi T., and Honda H. Three-dimensional high-density culture of HepG2 cells in a 5-ml radial-flow bioreactor for construction of artificial liver. J. Biosci. Bioeng. 99 (2005) 237-244
15. Ikeda M., Sugiyama K., Mizutani T., Tanaka T., Tanaka K., Sekihara H., Shimotohno K., and Kato N. Human hepatocyte clonal cell lines that support persistent replication of hepatitis C virus. Virus Res. 56 (1998) 157-167
16. Iwahori T., Matsuura T., Maehashi H., Sugo K., Saito M., Hosokawa M., Chiba K., Masaki T., Aizaki H., Ohkawa K., and Suzuki T. CYP3A4 inducible model for in vitro analysis of human drug metabolism using a bioartificial liver. Hepatology 37 (2003) 665-673
17. Kanto T., Hayashi N., Takehara T., Hagiwara H., Mita E., Naito M., Kasahara A., Fusamoto H., and Kamada T. Buoyant density of hepatitis C virus recovered from infected hosts: two different features in sucrose equilibrium density-gradient centrifugation related to degree of liver inflammation. Hepatology 19 (1994) 296-302
18. Kawada M., Nagamori S., Aizaki H., Fukaya K., Niiya M., Matsuura T., Sujino H., Hasumura S., Yashida H., Mizutani S., and Ikenaga H. Massive culture of human liver cancer cells in a newly developed radial flow bioreactor system: ultrafine structure of functionally enhanced hepatocarcinoma cell lines. In Vitro Cell Dev. Biol. Anim. 34 (1998) 109-115
19. Kuo G., Choo Q.L., Alter H.J., Gitnick G.L., Redeker A.G., Purcell R.H., Miyamura T., Dienstag J.L., Alter M.J., Stevens C.E., et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244 (1989) 362-364
20. Lanford R.E., Guerra B., Lee H., Averett D.R., Pfeiffer B., Chavez D., Notvall L., and Bigger C. Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons. J. Virol. 77 (2003) 1092-1104
21. Layden T.J., Layden J.E., Ribeiro R.M., and Perelson A.S. Mathematical modeling of viral kinetics: a tool to understand and optimize therapy. Clin. Liver Dis. 7 (2003) 163-178
22. Layden-Almer J.E., Cotler S.J., and Layden T.J. Viral kinetics in the treatment of chronic hepatitis C. J. Viral Hepat. 13 (2006) 499-504
23. Lindenbach B.D., Evans M.J., Syder A.J., Wolk B., Tellinghuisen T.L., Liu C.C., Maruyama T., Hynes R.O., Burton D.R., McKeating J.A., and Rice C.M. Complete replication of hepatitis C virus in cell culture. Science 309 (2005) 623-626
24. Lohmann V., Korner F., Koch J., Herian U., Theilmann L., and Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285 (1999) 110-113
25. Martell M., Esteban J.I., Quer J., Genesca J., Weiner A., Esteban R., Guardia J., and Gomez J. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J. Virol. 66 (1992) 3225-3229
26. Murakami K., Ishii K., Ishihara Y., Yoshizaki S., Tanaka K., Gotoh Y., Aizaki H., Kohara M., Yoshioka H., Mori Y., Manabe N., Shoji I., Sata T., Bartenschlager R., Matsuura Y., Miyamura T., and Suzuki T. Production of infectious hepatitis C virus particles in three-dimensional cultures of the cell line carrying the genome-length dicistronic viral RNA of genotype 1b. Virology 351 (2006) 381-392
27. Pawlotsky J.M. Hepatitis C virus population dynamics during infection. Curr. Top. Microbiol. Immunol. 299 (2006) 261-284
28. Perelson A.S., Herrmann E., Micol F., and Zeuzem S. New kinetic models for the hepatitis C virus. Hepatology 42 (2005) 749-754
29. Poynard T., Yuen M.F., Ratziu V., and Lai C.L. Viral hepatitis C. Lancet 362 (2003) 2095-2100
30. Saito I., Miyamura T., Ohbayashi A., Harada H., Katayama T., Kikuchi S., Watanabe Y., Koi S., Onji M., Ohta Y., et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 6547-6549
31. Shimizu Y.K., Hijikata M., Iwamoto A., Alter H.J., Purcell R.H., and Yoshikura H. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J. Virol. 68 (1994) 1494-1500
32. Suzuki T., Omata K., Satoh T., Miyasaka T., Arai C., Maeda M., Matsuno T., and Miyamura T. Quantitative detection of hepatitis C virus (HCV) RNA in saliva and gingival crevicular fluid of HCV-infected patients. J. Clin. Microbiol. 43 (2005) 4413-4417
33. Tagawa M., Kato N., Yokosuka O., Ishikawa T., Ohto M., and Omata M. Infection of human hepatocyte cell lines with hepatitis C virus in vitro. J. Gastroenterol. Hepatol. 10 (1995) 523-527
34. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Krausslich H.G., Mizokami M., Bartenschlager R., and Liang T.J. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11 (2005) 791-796
35. Zhong J., Gastaminza P., Cheng G., Kapadia S., Kato T., Burton D.R., Wieland S.F., Uprichard S.L., Wakita T., and Chisari F.V. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 9294-9299